Isatin and substituted isatin derivatives possess a broad spectrum of biological activities. These moieties also have a wide scope for substitution, particularly at positions N-1 and C-3. Therefore, the study focused at synthesizing some novel isatin/substituted isatin Schiff’s bases and screening them for anti-cancer activity against MCF-7 cell lines. All the compounds were synthesized by conventional methods in a two-step synthesis. Mannich bases of isatin were synthesized by reacting secondary amines and 37% formalin, which were then reacted with primary aromatic amines in the presence of glacial acetic acid to yield the title compounds. All the compounds were characterized by physical, chromatographic and spectroscopic methods. The synthesized analogues showed good activity against MCF-7 cell lines when compared to the standard drug, Doxorubicin. At a concentration of 10µg/ml, the analogues IDF 3B, IDF 3G, IDF 3H and IDF 3I showed percentage cell viability of 35.46227 ± 12.92, 34.37412 ± 5.39, 35.81035 ± 5.25, 36.19748 ± 3.27 respectively compared to percentage cell viability of 22.36828 ± 2.35 for the standard. The obtained data indicated that the analogues were effective against breast cancer, and therefore the isatin moiety could serve as the lead to the development of new anti-breast cancer agents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.